12:00 AM
 | 
Jul 02, 2012
 |  BC Week In Review  |  Company News  |  Other News

Pharming biomanufacturing, cardiovascular news

Pharming said it closed its U.S.-based transgenic cattle research operations as part of cost containment measures to focus on its transgenic rabbit platform. The company said the closure reflects the "declining importance of transgenic cattle research." Last month, Pharming said it began a comprehensive review of strategic options, which could include a merger,...

Read the full 244 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >